Immunological configuration of ovarian carcinoma: features and impact on disease outcome

Código QR

Immunological configuration of ovarian carcinoma: features and impact on disease outcome

Guardado en:

Detalles Bibliográficos
Autores principales:	Lorenzo Galluzzi, Radek Špíšek, Jitka Fucikova, Sandra Orsulic
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/41a6a6f4be294017adab9289b598177b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
por: Chisato Ohe, et al.
Publicado: (2021)

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
por: Robert L. Hollis, et al.
Publicado: (2021)

Cancer immunology and immunotherapy
por: Xiubao Ren
Publicado: (2021)

The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma
por: Bin Xu MD, et al.
Publicado: (2021)

Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation
por: Sang-Ho Yoon, et al.
Publicado: (2021)

CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
por: Wenjun He, et al.
Publicado: (2021)

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
por: Tian Zhang, et al.
Publicado: (2021)

MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma
por: Feng Du MD, et al.
Publicado: (2021)

Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
por: Toshiki Kijima, et al.
Publicado: (2021)

Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Publicado: (2021)

The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Yuanyuan Lu MD, et al.
Publicado: (2021)

Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity
por: Elizabeth Repasky, et al.
Publicado: (2021)

Correction: Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity
Publicado: (2021)

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
por: Robert L. Hollis, et al.
Publicado: (2021)

Synchronous B-Cell Acute Lymphoblastic Leukemia and Serous Ovarian Carcinoma: A Case Report
por: Michael Superdock, et al.
Publicado: (2021)

GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Xiaolin Li, et al.
Publicado: (2021)

PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer
por: Xiaoting Li, et al.
Publicado: (2021)

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
por: Inken Flörkemeier, et al.
Publicado: (2021)

Correction: Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Publicado: (2021)

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
por: Lu Deng, et al.
Publicado: (2021)

Sonomammographic characteristics of invasive lobular carcinoma
por: El-Damshety O, et al.
Publicado: (2012)

Breast carcinomas: variations in sonoelastographic appearance
por: Fleury E, et al.
Publicado: (2014)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
por: Mary L Disis, et al.
Publicado: (2021)

Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer
por: Bin Zhang, et al.
Publicado: (2021)

Comprehensive molecular profiling of pulmonary pleomorphic carcinoma
por: Masaaki Nagano, et al.
Publicado: (2021)

Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance
por: Xianda Zhao, et al.
Publicado: (2021)

Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study
por: Patrick Leo, et al.
Publicado: (2021)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
por: Ya Cao
Publicado: (2017)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021)

Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma
por: Hao Zhang, et al.
Publicado: (2021)

The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis
por: Lei Chen, et al.
Publicado: (2021)

Unmasking the immune microecology of ductal carcinoma in situ with deep learning
por: Priya Lakshmi Narayanan, et al.
Publicado: (2021)

Mammographic texture features associated with contralateral breast cancer in the WECARE Study
por: Gordon P. Watt, et al.
Publicado: (2021)

Non-small-cell lung carcinoma: role of the Notch signaling pathway
por: Barse L, et al.
Publicado: (2015)

Hsa_circ_0013290 Acts as Cancer-Promoting Gene in Hepatocellular Carcinoma
por: Xi Luo, et al.
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: Wei He, et al.
Publicado: (2017)

Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma
por: Weibiao Zeng MD, et al.
Publicado: (2021)

The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Lei Chen, et al.
Publicado: (2021)

Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project
por: Mohammad A. J. Abdulla MD, et al.
Publicado: (2021)